Trademark: 87456851
Word
TBC-1002
Status
Dead
Status Code
606
Status Date
Monday, January 4, 2021
Serial Number
87456851
Mark Type
4000
Filing Date
Friday, May 19, 2017
Published for Opposition
Tuesday, October 3, 2017
Abandoned Date
Monday, January 4, 2021

Trademark Owner History
Tesorx Pharma, LLC - Owner At Publication

Classifications
5 Pharmaceuticals, namely, anti-cancer drugs; Pharmaceutical preparations for the treatment of bladder cancer

Trademark Events
Jan 4, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 4, 2021
Abandonment - No Use Statement Filed
Nov 5, 2020
Assigned To Examiner
Apr 2, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 1, 2020
Extension 5 Granted
Mar 30, 2020
Extension 5 Filed
Apr 1, 2020
Case Assigned To Intent To Use Paralegal
Mar 30, 2020
Teas Extension Received
Oct 5, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 3, 2019
Extension 4 Granted
Oct 3, 2019
Extension 4 Filed
Oct 3, 2019
Teas Extension Received
May 22, 2019
Notice Of Approval Of Extension Request E-Mailed
May 20, 2019
Extension 3 Granted
May 20, 2019
Extension 3 Filed
May 20, 2019
Teas Extension Received
Nov 14, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 12, 2018
Extension 2 Granted
Nov 12, 2018
Extension 2 Filed
Nov 12, 2018
Teas Extension Received
Apr 10, 2018
Notice Of Approval Of Extension Request E-Mailed
Apr 6, 2018
Extension 1 Granted
Apr 6, 2018
Extension 1 Filed
Apr 6, 2018
Teas Extension Received
Nov 28, 2017
Noa E-Mailed - Sou Required From Applicant
Oct 3, 2017
Official Gazette Publication Confirmation E-Mailed
Oct 3, 2017
Published For Opposition
Sep 13, 2017
Notification Of Notice Of Publication E-Mailed
Aug 20, 2017
Approved For Pub - Principal Register
Aug 18, 2017
Assigned To Examiner
May 25, 2017
New Application Office Supplied Data Entered In Tram
May 23, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24